Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2018-05-18

Original market date: See footnote 1

2000-10-26

Lot number: See footnote 2

1223527

Expiry date: See footnote 2

2009-07-31

Product name:

ALPROSTADIL INJECTION, USP

DIN:

02241680 Electronic product monograph is not available

Company:

NOVOPHARM LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous ,  Intra-Arterial

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

24:12.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

C01EA01 ALPROSTADIL

Active ingredient group (AIG) number:See footnote5

0115288001

List of active ingredient(s)
Active ingredient(s) Strength
ALPROSTADIL 500 MCG / ML
Version 4.0.2
Date modified: